UNCYUnicycive Therapeutics, Inc.vs its industry peers
A metric-by-metric comparison of Unicycive Therapeutics, Inc. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| UNCY본 종목 | $94M#8 | — | 1.8x#7 | 139.1x#7 | -29.0%#8 | 27.7%#3 | -4372.9%#7 | -49.8%#6 | — | — | — | — |
| NKTX | $108M#1 | — | 0.4x#2 | — | — | 4.3%#6 | — | -42.0%#5 | — | — | — | — |
| OKUR | $107M#2 | — | 0.6x#3 | — | — | -13.0%#9 | — | -34.6%#3 | — | — | -20.2%#1 | — |
| ANIX | $107M#3 | — | 7.4x#10 | 509.9x#8 | 0.0%#5 | 13.0%#4 | -5571.9%#8 | -75.5%#8 | -87.0%#2 | — | — | — |
| IMUX | $100M#4 | 3.6x#1 | 0.8x#5 | — | — | 3.3%#7 | — | -76.2%#9 | — | — | — | — |
| ORGO | $95M#5 | — | 0.6x#4 | 0.2x#1 | 17.0%#3 | 4011.1%#1 | 7.9%#1 | 25.0%#1 | 23.2%#1 | — | -82.5%#3 | — |
| NRXP | $95M#6 | — | — | 77.4x#5 | — | -13.9%#10 | -1324.4%#5 | — | — | — | — | — |
| GNLX | $94M#7 | — | 5.8x#9 | 11763.8x#10 | 0.0%#5 | -7.6%#8 | -415175.0%#10 | -199.5%#11 | -424.2%#5 | — | — | — |
| PLYX | $93M#9 | — | 8.5x#11 | — | — | 70.4%#2 | — | -82.1%#10 | — | — | — | — |
| MIST | $92M#10 | — | 5.1x#8 | — | — | -51.9%#12 | — | -0.3%#2 | — | — | — | — |
| LEXX | $89M#11 | — | 18.8x#12 | 126.2x#6 | 52.0%#1 | -105.4%#13 | -1683.0%#6 | -251.2%#12 | — | — | — | — |
| EQ | $88M#12 | — | 1.6x#6 | 2.1x#2 | 13.9%#4 | -177.6%#14 | -57.5%#3 | -40.0%#4 | -368.9%#4 | — | — | — |
| TNXP | $87M#13 | — | 0.4x#1 | 6.7x#3 | 29.8%#2 | 4.6%#5 | -959.1%#4 | -55.8%#7 | -234.8%#3 | — | -72.6%#2 | — |
| NTHI | $85M#14 | — | — | 2120.8x#9 | -51.8%#9 | -422.3%#15 | -145637.5%#9 | — | — | — | — | — |
| EMMA | $84M#15 | — | — | 6.8x#4 | -25.2%#7 | -16.1%#11 | 1.9%#2 | — | — | 4#1 | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-11-03.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice